Ongoing Achievements and WorkstreamsASOP EU champions Article 85d of the FMD which legally obliges Member States and DG Sante to publicize the meaning of the Common Logo and a falsified medicine. ASOP EU has worked closely with the NABP to further the subscriptions of online pharmacies to adopt the Top level Domain name DotPharmacy. If the consumer knows of this website then they can be assured of legitimate and authentic medicines. These activities were continued during 2022. In particular closer liaison activity took place with the NABP attempting to introduce DotPharmacy gTLD into the UK.A new member the European association of E-Pharmacies has resulted in the DotPharmacy principle being of more interest in Europe and the vision is to introduce this concept using the translated term such as DotPharmacie for France, Dot Apoteke for Germany etc.The Digital Services Act (DSA) which will replace the E-Commerce Act is truly a significant event and ASOP EU are advocating strongly for more liability to be placed on the Internet Intermediaries. Close affiliation with ASOP Global and contributing to the Global initiatives which include a parallel pathway with communications to the VP at the White House and advocacy in the US Congress and close liaison with Homeland Security and the FDA. In Europe ASOP EU became a strong member of the Know Your Business Customer and was one of 86 organisations to be part of this community advocating for a broadened scope of the DSA to include all intermediaries not just online marketplaces. ASU wrote letters to the Commission, the Council and the Parliament as well as the President advocation for the KYBC principles. During 2022 the above advocacy has continued and ASOP EU is now closely monitoring the introduction of the DSA. Recently a meeting was convened with key players in the pharmaceutical industry the EUIPO/Observatory to raise awareness about the practical effect of the DSA introduction and how it will aid better governance of the InternetAdvocating for an enhanced NIS2 legislation by working closely with the KYBC community. Further UK legislation is in the offing and the ASOP EU contributed to a recent submission.Being part of the EUIPO Observatory as a Civil Society Member and speaking and championing the rights of patient safety in the various working groups. ASOP EU was part of an expert WG on Domain names and a comprehensive report was issued on this subject to underline best practice in this area. This support to the Observatory continued in 2022. ASOP EU has now been part of two significant Expert working groups (EWG) notably the “Domain Names” EWG and the “Search Engine” EWG.As per point 1 - Participating in endorsing the NABP .pharmacy initiative and being part of the .Pharmacy Registrant/Supporter Advisory Committee and championing the .pharmacy initiative as a more robust solution than the Common Logo which has already been cut and pasted by criminals.ASOP EU became official observers of the Committee of Parties (CotP) Member of the ratified Medicrime Convention. ASOP EU are in the process of recommending the DOT pharmacy initiative to the CotP as well as running longitudinal market research by each ratified country. This initiative is ongoing and due to a hiatus in the MC proceedings, it was delayed.Production of a July 2022 newsletterMany speaking engagements including invitations to speak at various conferences.

Consultation is ongoing throughout the year with Members and Observers. The relationship with law enforcement with the MHRA has been particularly strong, as is the relationship with its sister organisation ASOP Global. ASOP EU also facilitated EURid and the National Association of Boards of Pharmacy (NABP) acting synergistically to check suspicious websites.Close liaison with the Secretariat of the Medicrime Convention Committee of the Parties took place and attendance at the virtual meetings.2022 like 2021 was characterized by an enhanced meeting schedule held virtually. Advocacy letters on the Digital Services Act involved other organisations as co-signatories and the letter can be found here https://www.kybc.eu/wp-content/uploads/2021/07/Co-signed-letter-to-EU-Parliament-re-DSA-18-June-2021F2.pdf. Discussions with the European Association for e-Pharmacies were ongoing which resulted in them rejoining as members and an agreement to work together more closely.

No remuneration was received

No transfer of assets other than for full consideration